26. COST-UTILITY ANALYSES OF GLOFITAMAB FOR THE TREATMENT OF PATIENTS WITH RELAPSEDREFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY IN ITALY
- Versione
- Download 0
- Dimensioni file 281.90 KB
- Conteggio file 1
- Data di creazione Gennaio 7, 2025
- Ultimo aggiornamento Gennaio 7, 2025